MAIURI, LUIGI
 Distribuzione geografica
Continente #
NA - Nord America 2.530
EU - Europa 1.954
AS - Asia 837
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 6
AF - Africa 1
SA - Sud America 1
Totale 5.337
Nazione #
US - Stati Uniti d'America 2.529
IE - Irlanda 727
CN - Cina 627
UA - Ucraina 567
SE - Svezia 395
FI - Finlandia 131
IN - India 117
GB - Regno Unito 61
TR - Turchia 57
SG - Singapore 34
DE - Germania 21
BE - Belgio 20
IT - Italia 12
EU - Europa 8
RU - Federazione Russa 8
NZ - Nuova Zelanda 5
CZ - Repubblica Ceca 4
FR - Francia 4
DK - Danimarca 2
AT - Austria 1
AU - Australia 1
CA - Canada 1
IR - Iran 1
PK - Pakistan 1
PL - Polonia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.337
Città #
Dublin 726
Chandler 510
Jacksonville 407
Dearborn 285
Nyköping 263
Nanjing 220
Ashburn 155
Wilmington 93
Princeton 82
San Mateo 81
Beijing 75
Des Moines 75
Nanchang 73
Ann Arbor 71
Helsinki 50
Pune 43
Shenyang 40
Boardman 39
Woodbridge 39
Hebei 33
Changsha 30
Kunming 30
Tianjin 24
Hangzhou 22
Jiaxing 22
Brussels 20
Seattle 17
Singapore 15
Hilden 14
Los Angeles 13
Lanzhou 10
New York 10
Zhengzhou 8
Jinan 7
Washington 7
Philadelphia 6
Changchun 5
Naples 5
Ningbo 5
Guangzhou 4
Foggia 3
Hefei 3
Norwalk 3
Orange 3
Phoenix 3
Shanghai 3
Auburn Hills 2
Borås 2
Fuzhou 2
Glasgow 2
Hvidovre 2
Olomouc 2
Redwood City 2
Saint Petersburg 2
Stevenage 2
Wuhan 2
Ardabil 1
Auckland 1
Calumet City 1
Caserta 1
Chaoyang 1
Dunedin 1
Edinburgh 1
Haikou 1
Harbin 1
Houston 1
Kernersville 1
Lahore 1
Leicester 1
Limerick 1
London 1
Melbourne 1
Montevideo 1
Mountain View 1
Orland Park 1
Owings Mills 1
Perugia 1
Pinehaven 1
Redmond 1
Rockville 1
Shaoxing 1
Sousse 1
Taizhou 1
Tauranga 1
Vienna 1
Walnut 1
Warsaw 1
Yeovil 1
Totale 3.704
Nome #
In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA 127
Blockage of T-cell costimulation inhibits T-cell action in celiac disease. 101
Interleukin 15 mediates epithelial changes in celiac disease. 96
Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. 93
Prevention by mannan and other sugars of in vitro damage of rat fetal small intestine induced by cereal prolamin peptides toxic for human celiac intestine. 85
Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. 85
A search for the holy grail: non-toxic gluten for celiac patients 84
Celiac disease: In vitro and in vivo safety and palatability of wheat-free sorghum food products. 84
Effects of gluten enriched diet on the small intestinal mucosa of normal mice and mice with graft versus host reaction. 82
Analysis of lactase processing in rabbit. 82
Gluten-sensitive disease with mild enteropathy 82
Patchy expression of lactase protein in adult rabbit and rat intestine 80
Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. 79
Amines protect in vitro the celiac small intestine from the damaging activity of gliadin peptides. 79
A y(+)LAT-1 mutant protein interferes with y(+)LAT-2 activity: implications for the molecular pathogenesis of lysinuric protein intolerance 78
Imaging active lymphocytic infiltration in coeliac disease with iodine-123-interleukin-2 and the response to diet. 77
Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides. 77
Choroid plexus carcinoma in a child: a case report 77
High incidence of spontaneous autoimmune thyroiditis in immunocompetent self-reactive human T cell receptor transgenic mice 76
Endomysial antibodies as unreliable markers for slight dietary transgressions in adolescents with celiac disease. 76
Mosaic differentiation of human villus enterocytes: patchy expression of blood group A antigen in A nonsecretors. 76
Unconjugated bilirubin modulates the intestinal epithelial barrier function in a human-derived in vitro model 75
Celiac disease: a model autoimmune disease with gene therapy applications 75
Lactase persistence versus decline in human adults: multifactorial events are involved in down-regulation after weaning. 75
L-15 drives the specific migration of CD94+ and TCR-gammadelta+ intraepithelial lymphocytes in organ cultures of treated celiac patients. 74
In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa. 73
Cranial metastases of neuroblastoma of unusual size 73
Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood 71
Gliadin as stimulator adaptive and innate immune responses in celiac disease. 70
Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients. 68
Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. 68
DNA fragmentation is a feature of cystic fibrosis epithelial cells: a disease with inappropriate apoptosis? 68
Malignant extradural spinal cord compression in childhood: diagnostic, surgical, and prognostic considerations with respect to 6 cases 68
The lipid A of Burkholderia multivorans C1576 smooth-type lipopolysaccharide and its pro-inflammatory activity in a cystic fibrosis airways model 67
Evidence of still-ongoing convergence evolution of the lactase persistence T-13910 alleles in humans. 67
Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosa. 67
Reactive nitrogen species modulate the effects of rhein, an active component of senna laxatives, on human epithelium in vitro 67
Cellular basis of adult-type hypolactasia 67
Immunologic and intestinal permeability tests as predictors of relapse during gluten challenge in childhood coeliac disease. 67
Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease 66
Surface staining on the villus of lactase protein and lactase activity in adult-type hypolactasia. 66
Gliadin as a stimulator of innate responses in celiac disease 65
Evidence of chronic inflammation in morphologically normal small intestine of cystic fibrosis patients. 65
In vitro biosynthesis of lactase in preweaning and adult rabbit. 63
Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice 63
Celiac Disease: a common food intolerance on an immunological basis 63
Inhibition of p38 mitogen activated protein kinase controls airway inflammation in cystic fibrosis 62
Morphological method for the diagnosis of human adult type hypolactasia. 62
Cytotoxic effect of prolamin-derived peptides on in vitro cultures of cell line Caco-2: Implications for coeliac disease. 62
Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. 61
Mosaic regulation of lactase in human adult-type hypolactasia 61
Efficacy of budesonide therapy in the early phase of treatment of adult celiac disease patients with malabsorption: An in vivo/in vitro pilot study 60
Cellular basis of adult-type hypolactasia. 60
Cellular basis of adult-type hypolactasia 58
Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure (vol 120, pg 203, 2010) 58
Intestinal mucosa of celiacs in remission is unable to abolish toxicity of gliadin peptides on in vitro developing fetal rat intestine and cultured atrophic celiac mucosa. 57
Cerebral artery aneurysms in childhood 57
In vitro biosynthesis of lactase in suckling and adult rabbits. Regulatory mechanisms involved in the decline of the lactase activity. 56
Unexpected role of surface transglutaminase type II in celiac disease 55
Cystic fibrosis: a disorder with defective autophagy 55
Gluten sensitive disease with mild enteropathy 55
FAS engagement drives apoptosis of enterocytes of coeliac patients. 54
Diagnostic morphological methods: Use of immunomorphological and enzymo-histochemical methods for a single disease entity 54
Introduction to oxidative stress and antioxidant therapy 52
Is there a direct specific cytotoxic effect of gliadin on the intestinal mucosa in celiac disease? 51
Headache in pediatric patients with celiac disease and its prevalence as a diagnostic clue 50
Sturge-Weber disease without facial nevus 50
Vertebral osteoid osteoma, rare cause of nerve root compression and scoliosis in childhood 50
In vitro biosynthesis of lactase proteins in human small intestinal tissues with persistent high lactase activity and with adult-type hypolactasia 50
Plexiform neurofibroma of the occipital scalp 48
Giant spinal lipoma extending into the posterior fossa in a 6 months old child 48
The human adult-type hypolactasia is a heterogeneous condition in in vitro biosynthetic studies 47
In vitro organ culture system 47
Mucosal cell-mediated immunity in Coeliac Disease 47
Intracranial germinomas: two cases with review of the literature 45
In vitro gluten challenge 45
Epilepsy caused by vascular insufficiency as a result of a malformation in a child 44
Semilobar holoprosencephaly: embryologic, CSF dynamics and radiological considerations. 42
Guidelines for the use and interpretation of assays for monitoring autophagy 42
Nebulized Hyaluronan Ameliorates lung inflammation in cystic fibrosis mice 42
Lactase activity of the enterocytes of human proximal jejunum with adult-type hypolactasia 40
The lipid A of Burkholderia multivorans C1576 smooth-type lipopolysaccharide and its pro-inflammatory activity in a cystic fibrosis airways model. 38
Totale 5.352
Categoria #
all - tutte 23.274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.274


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.173 274 145 18 23 148 148 195 8 105 17 85 7
2020/2021575 86 0 78 7 82 52 89 4 82 89 5 1
2021/2022397 90 1 10 4 26 5 10 34 41 36 15 125
2022/20231.989 187 89 140 133 113 187 48 142 864 14 33 39
2023/2024385 56 12 18 10 41 125 28 53 0 10 2 30
2024/20254 4 0 0 0 0 0 0 0 0 0 0 0
Totale 5.352